ACE2 and COVID-19: Moreover, expression of the SARS‐CoV‐2 receptor, angiotensin‐converting enzyme 2 (ACE2), by neuronal and glial cells makes the brain susceptible to neuro‐invasion (Chen et al, 2020; Xu & Lazartigues, 2020) and COVID‐19 human patients frequently present neurological symptoms (Bourgonje et al, 2020; Hu et al, 2020; Mao et al, 2020).